Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Palliat Med ; 22(8): 1009-1013, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30864873

RESUMEN

Introduction: Terminal bleeding, a distressing symptom experience for patients, caregivers, and health professionals, occurs in a subset of patients in the palliative care setting. Terminal bleeding is often thought of as a large-volume catastrophically fatal event, but it can also occur for a longer period of time and still be the precipitating event for a patient's death. Case Report: We present the case of terminal bleeding in an 87-year-old patient with angiosarcoma, a rare aggressive vascular neoplasm that can occur anywhere in the body but tend to occur more frequently in the head and neck. Discussion: The patient's advanced age and aggressive disease presented challenges in managing the symptoms and precluded many of the conventional recommended interventions to manage bleeding. Conclusion: This case report speaks to the need for multidisciplinary planning that takes prognosis, performance status, previous therapies, and patient preferences into account when caring for patients with advanced cancer.


Asunto(s)
Hemangiosarcoma/complicaciones , Hemangiosarcoma/enfermería , Hemorragia/etiología , Hemorragia/enfermería , Cuidados Paliativos/métodos , Anciano de 80 o más Años , Resultado Fatal , Femenino , Humanos
2.
Clin J Oncol Nurs ; 22(6): 597-599, 2018 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-30452012

RESUMEN

Venous flare reaction, a localized allergic response associated with the administration of an irritant, is one of the most common chemotherapy infusion-related reactions. Etoposide, a drug commonly used in patients with lung cancer, has been reported to be an irritant with vesicant properties depending on the volume administered. This article presents the case of a patient who has a venous flare reaction immediately following the administration of etoposide for the treatment of diffuse large B-cell lymphoma. Managing such complications is crucial to maintaining patient safety. Proper training and education should be incorporated into nursing practice when identifying, preventing, and managing such reactions.


Asunto(s)
Antineoplásicos/efectos adversos , Etopósido/efectos adversos , Hipersensibilidad/enfermería , Linfoma de Células B Grandes Difuso/tratamiento farmacológico , Vasculitis/inducido químicamente , Anciano , Antineoplásicos/administración & dosificación , Etopósido/administración & dosificación , Humanos , Hipersensibilidad/terapia , Infusiones Intravenosas/efectos adversos , Linfoma de Células B Grandes Difuso/diagnóstico , Masculino , Enfermería Oncológica/métodos , Seguridad del Paciente , Medición de Riesgo , Venas/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA